Westpfalz-Klinikum

A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. (2024) Kießler M, Jäger C, Mota Reyes C, Pergolini I, Schorn S, Göß R, Safak O, et al. Journal article The impact of the tumor microenvironment on the survival of penile cancer patients. (2024) Lohse S, Mink JN, Eckhart L, Hans MC, Jusufi L, Zwick A, Mohr T, et al. Journal article Single or Double Induction With 7 1 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia (2024) Röllig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Hänel M, et al. Journal article Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study) (2024) Stumpf J, Thomusch O, Opgenoorth M, Wiesener M, Pascher A, Woitas RP, Suwelack B, et al. Journal article Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas (2023) Mink JN, Khalmurzaev O, Pryalukhin A, Geppert CI, Lohse S, Bende K, Lobo J, et al. Journal article Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia (2023) Kayser S, Martínez-Cuadrón D, Rodriguez-Veiga R, Hänel M, Tormo M, Schäfer-Eckart K, Botella C, et al. Journal article Bedeutung von HPV-Status und p16 für die Prognose des Peniskarzinoms (2023) Mink JN, Khalmurzaev O, Pryalukhin A, Hölters S, Geppert CI, Lohse S, Bende K, et al. Journal article Pediatric multi-drug-resistant tuberculosis in Germany – diagnostic and therapeutic challenges of an “orphan disease” (2023) Schäfer HL, Barker M, Follmann P, Günther A, Hörning A, Kaiser-Labusch P, Kerzel S, et al. Journal article Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience (2023) Enßle JC, Wolf S, Scheich S, Weber S, Kramer M, Ruhnke L, Schliemann C, et al. Journal article Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial (2022) Roellig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Haenel M, et al. Conference contribution